drugset / Trial / NCT00097032

Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients

NCT00097032

RandomizedCrossoverDouble-blind

Summary

The purpose of this study is to determine whether the sedating (causing sleepiness) effects of risperidone or quetiapine alter cognitive (person's ability to think, perceive, recognize, remember, judge, and reason) functioning in subjects with stable Bipolar I Disorder.

Timeline

Start
2004-10
Primary completion
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule 100 mg
Subject Risperidone Other / unclassified 2 mg

Indications